Form D · Other
Pearl Biosciences, LLC
State College, PA · CIK 0001488203
Offering snapshot reported Apr 5, 2010 · SEC filing
- Reported sold
- $175K Offering amount: $175K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 26, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 5, 2010 | Initial | $175,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-140171
Convertible debt
Source: Form D, filed Apr 5, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Dermot Boyle | Director |
| Mark Wayne Du Mars | Director, Executive |
| Roy H. Hammerstedt | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
1981 Pine Hall Drive
State College, PA, 16801
State College, PA, 16801